An interview with Andrew Hill, Ph.D., about his research presented at AIDS 2020.
This Champion of Community’s Role in Clinical Trials Reflects on 40 Years of Fighting Medical Mistrust And Research Neglect
Wakefield retires from the HIV Vaccine Trials Network after 20 years of service.
Richard Jefferys of Treatment Action Group discusses the pipeline for new modalities being explored for treatment, PrEP, vaccine, and cure.
LaRon Nelson, Ph.D., RN, talks about public health’s responsibility to meet this extraordinary moment.
Legal groups provide pathways to reducing coronavirus spread in carceral settings.
Will We Ever Have a Hepatitis C Vaccine? Two Activists Weigh in on the Challenges and Opportunities Ahead
A new injection of funding from Congress could be the catalyst for a future hepatitis C (HCV) vaccine.
This researcher has some ideas about what we need to do to address the problem.
Natalia Linos, Sc.D., M.Sc., of Harvard University’s FXB Center for Health and Human Rights, calls for protections for low-wage essential workers and releasing people from jails, prisons, and ICE detention.
Two researchers discuss their analysis of Philadelphia FIGHT’s HIV pre-exposure prophylaxis (PrEP) program for cisgender women.
A Longtime HIV/LGBTQ Doctor Volunteered in a New York City Public Hospital Against COVID-19. Here’s What He Learned.
“It was like you were in the Lifetime movie version of a hospital,” Mayer said.